Pharmaceutical Technology's In the Lab eNewsletter
The risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Damon Asher
Advertisement
Damon Asher, PHD, is associate director Americas vaccine and viral therapies, MilliporeSigma.
Articles by Damon Asher
Advertisement
Latest Updated Articles
Preventing Microbial Contamination of Viral Vaccines and VectorsOctober 3rd 2018
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push
3
USP Reports Drug Discontinuations on the Rise
4
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
5